🇧🇷 Peptide Regulations in Brazil
Legal Status
Brazil regulates pharmaceuticals under Law No. 6.360/1976 and its implementing regulations, with ANVISA serving as the primary regulatory authority. Peptides intended for therapeutic use must be registered with ANVISA before commercial sale. Brazil has a robust generic and biosimilar regulatory framework, and several peptide drugs (including growth hormone formulations) are registered and available through the Unified Health System (SUS). Research chemicals for in vitro use can be imported through registered chemical distributors, but importing pharmaceutical-grade peptides as medicines is heavily restricted. ANVISA has been modernising its regulatory framework, with Resolution RDC No. 753/2022 updating pharmaceutical registration requirements.
Compounding Rules
- Compounding (manipulação magistral) is regulated under RDC No. 67/2007 and is well-established in Brazil's pharmacy system.
- Compounding pharmacies (farmácias de manipulação) must hold an ANVISA operating authorisation and comply with Good Compounding Practices.
- Magistral formulas require a prescription from a registered healthcare professional.
- Officinal formulas may be prepared according to the Brazilian Pharmacopoeia without a specific prescription.
- Brazil's compounding pharmacy sector is one of the largest in the world, many peptide preparations are available through this channel.
- ANVISA periodically audits compounding pharmacies and can suspend or revoke operating authorisations for non-compliance.
⚠ Key Warnings
- ANVISA has strong enforcement powers and regularly detains unauthorized pharmaceutical shipments.
- Selling unregistered pharmaceutical products in Brazil carries penalties of 1–5 years imprisonment under Law 5.991/1973.
- The Brazilian postal service (Correios) and Receita Federal have automated systems for detecting pharmaceutical shipments.
- Growth hormone, anabolic steroids, and certain peptides are classified as controlled substances and face additional restrictions.
- Brazil's anti-doping authority (ABCD) follows the WADA Prohibited List, athletes are subject to testing and penalties for peptide use.
How to Verify Legality
- Search ANVISA's product registration database (Consulta de Produtos) at gov.br/anvisa.
- Check the Brazilian Pharmacopoeia for quality monographs and standards.
- Verify pharmacy operating authorisations through ANVISA's establishment database.
- Review Portaria SVS 344/1998 for the controlled substances list.
- Contact ANVISA's customer service (Atendimento ao Cidadão) for regulatory queries about specific products.
Last updated: 2025-06
This information is for educational purposes only and does not constitute legal advice. Regulations change frequently and may vary by jurisdiction within a country. Always consult qualified local legal counsel before purchasing, importing, or using peptide compounds.
